Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
31261
-
31262
-
31263
-
31264
-
31265
-
31266
-
31267
-
31268
-
31269
Image_1_Anthralin Suppresses the Proliferation of Influenza Virus by Inhibiting the Cap-Binding and Endonuclease Activity of Viral RNA Polymerase.TIF
Published 2020“…The mechanism of action study revealed that anthralin inhibits the cap-binding function of PB2 subunit and endonuclease activity of PA. As a result, viral mRNA transcription is blocked, leading to the decreases in viral RNA replication and viral protein expression. …”
-
31270
Image_2_Anthralin Suppresses the Proliferation of Influenza Virus by Inhibiting the Cap-Binding and Endonuclease Activity of Viral RNA Polymerase.TIF
Published 2020“…The mechanism of action study revealed that anthralin inhibits the cap-binding function of PB2 subunit and endonuclease activity of PA. As a result, viral mRNA transcription is blocked, leading to the decreases in viral RNA replication and viral protein expression. …”
-
31271
Genetic resistance to DEHP-induced transgenerational endocrine disruption
Published 2019“…A DEHP-susceptibility allele in C57BL/6J contained five SNPs (rs28279710, rs32977910, rs46648903, rs46677594 and rs48287999) affecting SHP and six genes (<i>Svs2</i>, <i>Svs3b</i>, <i>Svs4</i>, <i>Svs3a</i>, <i>Svs6</i> and <i>Svs5)</i> epigenetically silenced by DEHP. …”
-
31272
-
31273
-
31274
-
31275
-
31276
-
31277
-
31278
Supplementary file 1_Persistent neurocognitive abnormalities as clinical sequelae of mild to moderate COVID-19.docx
Published 2025“…Seroconversion to anti-SARS-CoV-2 IgG was detected in 49 (87.5%) out of 56 patients tested and was more common among those with a more severe course of the infection.…”
-
31279
DataSheet1_The Influence of CYP3A4 Genetic Polymorphism and Proton Pump Inhibitors on Osimertinib Metabolism.docx
Published 2022“…The results demonstrated that the relative clearance rates of CYP3A4.19, 10, 18, 5, 16, 14, 11, 2, 13, 12, 7, 8, and 17 in catalyzing osimertinib were significantly reduced to a minimum of 25.68% compared to CYP3A4.1, while those of CYP3A4.29, 32, 33, 28, 15, 34, and 3 were obviously enhanced, ranging from 114.14% to 284.52%. …”
-
31280